Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Selectins and their ligands are required for homing and engraftment of BCR-ABL1 + leukemic stem cells in the bone marrow niche

Daniela S. Krause, Katherine Lazarides, Juliana B. Lewis, Ulrich H. von Andrian, Richard A. Van Etten

Blood (2014) 123 (9): 1361–1371.

https://doi.org/10.1182/blood-2013-11-538694

Published: 2014

Includes: Supplemental data

Journal Articles

BCR-ABL1 + Leukemic Stem Cells Are Dependent On Selectin-Ligand Interactions For Engraftment In The Bone Marrow Niche

Daniela S. Krause, M.D., Ph.D., Katherine Lazarides, B.S., Juliana B. Lewis, Ph.D., Ulrich H. von Andrian, M.D., Ph.D., David T. Scadden, M.D., Richard A. Van Etten, M.D., Ph.D.

Blood (2013) 122 (21): 2703.

https://doi.org/10.1182/blood.V122.21.2703.2703

Published: 2013

Journal Articles

Essential role for Stat5a/b in myeloproliferative neoplasms induced by BCR-ABL1 and JAK2 V617F in mice

Christoph Walz, Wesam Ahmed, Katherine Lazarides, Monica Betancur, Nihal Patel, Lothar Hennighausen, Virginia M. Zaleskas, Richard A. Van Etten

Blood (2012) 119 (15): 3550–3560.

https://doi.org/10.1182/blood-2011-12-397554

Published: 2012

Includes: Supplemental data

Journal Articles

Distinct graft-versus-leukemic stem cell effects of early or delayed donor leukocyte infusions in a mouse chronic myeloid leukemia model

Yi-Fen Lu, L. Cristina Gavrilescu, Monica Betancur, Katherine Lazarides, Hans Klingemann, Richard A. Van Etten

Blood (2012) 119 (1): 273–284.

https://doi.org/10.1182/blood-2011-01-331009

Published: 2012

Includes: Supplemental data

Journal Articles

Essential Role for Stat5a/b in Myeloproliferative Neoplasms Induced by BCR-ABL1 and Jak2 V617F.

Christoph Walz, MD, Katherine Lazarides, Nihal Patel, Lothar Hennighausen, PhD, Virginia M. Zaleskas, MD, Richard A. Van Etten, MD, PhD

Blood (2009) 114 (22): 312.

https://doi.org/10.1182/blood.V114.22.312.312

Published: 2009

Journal Articles

Switch Pocket Inhibitors of the ABL Tyrosine Kinase: Distinct Kinome Inhibition Profiles and in Vivo Efficacy in Mouse Models of CML and B-Lymphoblastic Leukemia Induced by BCR-ABL T315I

Richard A. Van Etten, MD, PhD, Wayne W. Chan, BA, Virginia M. Zaleskas, MD, Christoph Walz, MD, Peter Evangelista, BA, Katherine Lazarides, BS, Monica Betancur, MS, Scott Wise, MS, Peter A. Petillo, PhD, Daniel L. Flynn, PhD

Blood (2008) 112 (11): 576.

https://doi.org/10.1182/blood.V112.11.576.576

Published: 2008

Journal Articles

DCC-2036: A Novel Switch Pocket Inhibitor of ABL Tyrosine Kinase with Therapeutic Efficacy Against BCR-ABL T315I In Vitro and in a CML Mouse Model.

Richard A. Van Etten, MD, PhD, Wayne W. Chan, BS, Virginia M. Zaleskas, MD, PhD, Peter Evangelista, BS, Katherine Lazarides, BS, Cong Peng, PhD, Shaoguang Li, MD, PhD, Scott C. Wise, PhD, Peter Petillo, PhD, Daniel L. Flynn, PhD

Blood (2007) 110 (11): 463.

https://doi.org/10.1182/blood.V110.11.463.463

Published: 2007

Journal Articles

A Selective and Potent Oral Inhibitor of the JAK2 Tyrosine Kinase Reverses Polycythemia and Leukocytosis Induced by JAK2 V617F in a Mouse Model.

Virginia M. Zaleskas, MD, Wayne W. Chan, BS, Peter Evangelista, BS, Katherine Lazarides, BS, Rajesh Chopra, MD, Michael Zinda, PhD, Dennis Huszar, PhD, Richard A. Van Etten, MD PhD

Blood (2007) 110 (11): 557.

https://doi.org/10.1182/blood.V110.11.557.557

Published: 2007

Journal Articles

CD44 Is Selectively Required for the Homing and Engraftment of BCR-ABL-Expressing Leukemic Stem Cells.

Daniela S. Krause, MD, PhD, Katherine Lazarides, BS, Ulrich H. von Andrian, MD, PhD, Richard A. Van Etten, MD, PhD

Blood (2006) 108 (11): 743.

https://doi.org/10.1182/blood.V108.11.743.743

Published: 2006

Journal Articles

Molecular Pathogenesis of Polycythemia Induced in Mice by JAK2 V617F.

Virginia M. Zaleskas, MD, Daniela S. Krause, MD, PhD, Katherine Lazarides, BS, Nihal Patel, BS, Yiguo Hu, BS, Shaoguang Li, MD, PhD, Richard A. Van Etten, MD, PhD

Blood (2005) 106 (11): 116.

https://doi.org/10.1182/blood.V106.11.116.116

Published: 2005

NARROW

Selectins and their ligands are required for homing and engraftment of BCR-ABL1 + leukemic stem cells in the bone marrow niche

BCR-ABL1 + Leukemic Stem Cells Are Dependent On Selectin-Ligand Interactions For Engraftment In The Bone Marrow Niche

Essential role for Stat5a/b in myeloproliferative neoplasms induced by BCR-ABL1 and JAK2 V617F in mice

Distinct graft-versus-leukemic stem cell effects of early or delayed donor leukocyte infusions in a mouse chronic myeloid leukemia model

Essential Role for Stat5a/b in Myeloproliferative Neoplasms Induced by BCR-ABL1 and Jak2 V617F.

Switch Pocket Inhibitors of the ABL Tyrosine Kinase: Distinct Kinome Inhibition Profiles and in Vivo Efficacy in Mouse Models of CML and B-Lymphoblastic Leukemia Induced by BCR-ABL T315I

DCC-2036: A Novel Switch Pocket Inhibitor of ABL Tyrosine Kinase with Therapeutic Efficacy Against BCR-ABL T315I In Vitro and in a CML Mouse Model.

A Selective and Potent Oral Inhibitor of the JAK2 Tyrosine Kinase Reverses Polycythemia and Leukocytosis Induced by JAK2 V617F in a Mouse Model.

CD44 Is Selectively Required for the Homing and Engraftment of BCR-ABL-Expressing Leukemic Stem Cells.

Molecular Pathogenesis of Polycythemia Induced in Mice by JAK2 V617F.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only